2013-01-15 13:02:21 - New Pharmaceuticals market report from Datamonitor: "Forecast: Non-Small Cell Lung Cancer in China"
Pharmaceutical companies have been attracted by the high incidence of NSCLC in China and the pipeline has grown substantially. The treatment of NSCLC will continue to evolve as key brands come off patent and new therapies are launched in the Chinese market.
* Patient-based sales forecast for drugs in the Chinese NSCLC market from 2012 to 2021.
* In-depth analysis of the factors influencing the NSCLC market in Tier 1 and Tier 2 cites in China.
The NSCLC market in China will experience an increase from $707m to over $933m in Tier 1 and Tier 2 cites in China over the forecast period 2012-21.
Reasons to Get this Report
* Quantify the performance of each NSCLC drug in Tier 1 and
Tier 2 cites in China by sales and patient number.
* Gain insight into the key trends in the NSCLC market in China.
Report Table of Contents:
Datamonitor key findings
Methodology and Market Definition
Market definition for non-small cell lung cancer
Forecast methodology and assumptions
Additional forecast methodology
Market Overview and Context
Cancer therapies included in this analysis
Current and future market dynamics overview
Avastin (bevacizumab; Roche)
Iressa (gefitinib; AstraZeneca)
Tarceva (erlotinib; Roche)
Conmana (icotinib; Beta Pharma)
Alimta (pemetrexed; Eli Lilly) and pemetrexed (generics)
Gemzar (gemcitabine; Eli Lilly) and gemcitabine (generics)
Xalkori (crizotinib; Pfizer)
Dacomitinib (PF-00299804; Pfizer)
Tomtovok (afatinib; Boehringer Ingelheim)
Apatinib (Jiangsu Hengrui)
Journal papers and print sources
Full Report Details at
- www.fastmr.com/prod/529654_forecast_nonsmall_cell_lung_cancer_in ..
The Datamonitor Group is a world-leading provider of premium global business information, delivering independent data, analysis and opinion across the Automotive, Consumer Markets, Energy & Utilities, Financial Services, Logistics & Express, Pharmaceutical & Healthcare, Retail, Technology and Telecoms industries. Datamonitor's market intelligence products and services ensure that you will achieve your desired commercial goals by giving you the insight you need to best respond to your competitive environment. View more research from Datamonitor at www.fastmr.com/catalog/publishers.aspx?pubid=1002
About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.
For more information about these or related research reports, please visit our website at www.fastmr.com
or call us at 1.800.844.8156.